Considerations for NPC Therapy: Clinical Perspectives From Radiation Oncology
An expert discusses key considerations for nasopharyngeal carcinoma (NPC) therapy from the perspective of radiation oncology.
Video Player is loading.
Video content above is prompted by the following:
The patient from Case 1 received induction chemotherapy followed by concurrent chemoradiation as initial treatment following diagnosis.
- What are your thoughts on this treatment regimen given the disease presentation/diagnosis?
- How does elevated Epstein-Barr virus DNA impact your radiation treatment decision?
- What parameters would you monitor to assess response during and after radiation therapy?
Recent Videos
COMFORT Trials: Applying Evidence to Intermediate-Risk Myelofibrosis
Myelofibrosis Management: Clinical Approaches and Treatment Algorithms With Case-Based Application
Clinical Impact of COCOON: Advancing Dermatologic AE Management
Clinical Decision-Making Framework for Initiating Myelofibrosis Therapy
Clinical Approaches for Dermatologic AEs Associated With Amivantamab + Lazertinib in Advanced NSCLC
Prognostic Stratification on Myelofibrosis: From Models to Clinical Application
Ruxolitinib Therapy for cGVHD: Insights on Patient and Safety Monitoring
Personalized JAK Inhibitor Selection in Myelofibrosis: Clinical Characteristics, Molecular Profiles, and Treatment Sequencing
Advancing Treatment Paradigms in Myeloproliferative Neoplasms: From Molecular Pathogenesis to Patient-Tailored Therapy
Diagnostic Challenges in Myelofibrosis: Distinguishing Prefibrotic Disease
Related Content
